Role for tumor necrosis factor alpha receptor 1 and interleukin-1 receptorin the suppression of mouse hepatocyte apoptosis by the peroxisome proliferator nafenopin
Da. West et al., Role for tumor necrosis factor alpha receptor 1 and interleukin-1 receptorin the suppression of mouse hepatocyte apoptosis by the peroxisome proliferator nafenopin, HEPATOLOGY, 30(6), 1999, pp. 1417-1424
Peroxisome proliferators (PPs) cause rodent liver enlargement and tumors. I
n vitro, PPs induce rat and mouse hepatocyte DNA synthesis and suppress apo
ptosis, a response mimicked by exogenous tumor necrosis factor a (TNF alpha
), Here, we determine the role of TNF receptor I (TNFR1), TNF receptor 2 (T
NFR2), and nuclear factor kappa beta (NF kappa B) in the response of mouse
hepatocytes to the PP, nafenopin. Nafenopin (50 mu mol/L) induced DNA synth
esis as measured by bromodeoxyuridine (BrdU) incorporation, suppressed cell
death as measured by Hoechst 33258 staining, induced peroxisomal beta-oxid
ation as measured by cyanide insensitive palmitoyl CoA oxidation (PCO) and
caused activation of nuclear factor kappa beta (NF kappa B) as determined b
y electrophoretic mobility gel shift assay (EMSA). The induction of DNA syn
thesis and the suppression of apoptosis in response to nafenopin was abroga
ted completely by blocking antibodies to TNFR1 but not to TNFR2. In contras
t, the induction of peroxisomal beta-oxidation by nafenopin was not blocked
by the anti-TNFR1 antibody. Next, we evaluated the response of hepatocytes
to interleukin-1 (IL-1), another proinflammatory cytokine, IL-1 alpha (2.5
ng/mL) and, to a lesser extent, IL-1 beta (5 ng/mL), shared the ability of
TNF alpha to induce DNA synthesis and suppress apoptosis. In addition, ant
i-IL-1 receptor, type Yp80 (IL-IR) antibodies were able to abrogate the res
ponse to nafenopin, IL-1 alpha was still able to perturb hepatocyte growth
in the presence of the anti-TNFR1 antibody suggesting that IL-1 alpha acts
independently rather than by elaborating TNF alpha. In summary, these data
provide additional evidence for a role for hepatic cytokines in the perturb
ation of hepatocyte growth by PPs such as nafenopin.